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Conclusions: A stoichiometric calibration is feasible using all 
three parameterizations. The resulting mean-calibration 
curves are similar for all three methods. However, when 
introducing a random variation in the measured CT-numbers, 
as is manifest daily from scan to scan, the parameterization 
using 3 fitting parameters demonstrates significantly larger 
variation in the calculated CT-numbers of the theoretical 
tissues. The impact of this to the uncertainty in the proton 
ranges in human tissues will be studied further.  
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Purpose/Objective: Detailed knowledge of the esophageal 
tumor boundary is currently lacking. This uncertainty leads to 
large margins and risk of geographic miss during irradiation. 
Optical coherence tomography (OCT) is a minimally invasive 
and high resolution (1-10 µm) imaging technique that obtains 
cross-sectional images of tissue based on the backscattering 
of light. OCT has a great potential for esophageal cancer, as 
cylindrical probes exist that can scan the surface using a 
single rotating optical fiber. Fiducial markers have been 
successfully applied in a variety of treatment sites to provide 
guidance during tumor delineation and setup verification. 
Recently, we successfully placed markers at the proximal and 
distal tumor borders in esophageal cancer patients. 
Integration of the OCT with the CT used for treatment 
planning is an unsolved problem. Visibility of markers on OCT 
is crucial for an accurate registration of the OCT with the 
planning CT. This study aimed to investigate the visibility on 
OCT of two commercially available gold markers at 3 
different depths; enabling registration with CT.  
Materials and Methods: OCT is similar to ultrasound, 
however, it uses near infrared light instead of sound. While 
OCT has a 10 times higher resolution than ultrasound, it 
suffers from a limited penetration depth in the range of 2-3 
mm. We designed and manufactured a dedicated esophageal 
phantom, in which 3 different scattering materials represent 
esophageal wall layers (figure 1.A). Visicoil and Gold Anchor 
markers were implanted at different depths (≤0.2 mm, 0.6 
mm, and 1.2 mm) and imaged using an endoscopic OCT 
imaging system (Nvision VLE Imaging System, NinePoint 
Medical, Inc.). Further, to evaluate whether in current 
clinical practice the fiducial markers are placed within the 
OCT visualization range; we retrospectively measured the 
distance between the implanted gold markers and the inner 
wall of the esophagus on the planning CT of 7 patients who 
underwent endoscopy-guided marker implantation. 
Additionally, we manually coregistered the phantom OCT and 
CT images with use of the markers. 
Results: Figure 1.B shows that both types of gold markers are 
visible on OCT at all tested depths. Different scattering 
materials are visible on OCT. CT measurements from 7 
patients (9 fiducial markers) yield that on average the 
markers were implanted at a depth of 1.7 mm (range: 0.7-6.3 
mm) in the esophageal wall (table 1). For the 9 fiducial 
markers included in our retrospective analysis, 89% of the 
markers were placed at depths ≤2.0 mm and 44% were placed 
at depths ≤1.2 mm. Manual coregistration based on 2 markers 
was feasible (figure 1.C.). 
 
 
 
 
 
Conclusions: We have designed and manufactured a 
dedicated esophageal phantom, enabling the study of the 
visibility of two types of gold markers at different depths on 
OCT. The results indicate that both Visicoil and Gold Anchor 
markers are visible on OCT at depths ≤1.2 mm. Also, based 
on CT measurements, the majority of the markers in current 
clinical practice are already placed within the OCT 
visualization range. 
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Purpose/Objective: Hypoxia PET imaging may help to 
identify patients with radioresistant tumors. Previous studies 
identified the maximum tumor to background ratio (TBRm) in 
FMISO PET images as a potential prognostic parameter for 
local control. This study investigates the robustness of using a 
predefined TBRm threshold value to identify hypoxic tumors 
in multicenter clinical studies. Specifically, the effects of 
systematic deviations in the evaluation of TBRm between 
centers are analyzed. These are crucial due to the low 
contrast of hypoxia PET images. 
Materials and Methods: FMISO PET images were acquired 
four hours post injection for 20 patients with advanced head 
and neck carcinomas in a phase II FMISO dose escalation 
study. Median follow-up after definitive chemo-radiotherapy 
was 21 months (9-52 months). In a previous study based on 
this dataset the optimum threshold value for prognosis of 
local control was TBRm=1.9. Local control was significantly 
different between the two groups (p=0.005). 
The effect of systematic deviations in FMISO PET 
quantification between study centers are estimated by 
applying offsets of +/-10% and +/-20% to the evaluated TBRm 
values. Offsets of this magnitude may for example occur from 
different image reconstruction methods or due to variations 
in the definition of the background activity. The resulting 
Kaplan-Meier curves for these scenarios are compared by 
means of log-rank p-values. The TBRm threshold value for 
hypoxia is fixed at the previously defined value of 1.9. 
Results:An increase of TBRm by 10% and 20% in all patient 
datasets results in decreased significance levels of p=0.046 
and p=0.271, respectively. The initial value for undisturbed 
TBRm values was p=0.005. This situation may occur in study 
centers that systematically measure larger TBRm values 
compared to the conditions under which the reference 
threshold value was obtained. A decrease of TBRm by -10% 
and -20% results in a decrease to p=0.037 and p=0.310, 
respectively. This corresponds to a TBRm that is 
systematically smaller than under reference imaging 
conditions. 
Conclusions: The results indicate that for low contrast 
hypoxia PET imaging the stratification of patients into 
hypoxic/normoxic subgroups is very sensitive with respect to 
imaging parameters and image evaluation methods, such as 
the reconstruction method and the definition of background 
activity. This is particularly important in multicenter studies 
using, e.g., different PET scanners, imaging procedures and 
analysis tools. A careful standardization and harmonization 
between centers seems necessary to avoid severe losses in 
stratification accuracy.  
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Purpose/Objective: The relative motion of tumor and lymph 
node (LN) targets during treatment is unknown, but 
challenges the accuracy of lung cancer radiotherapy. The 
purpose of this study was to investigate the differential time-
resolved three-dimensional (3D) internal motion of lung 
tumors and LNs throughout the treatment course for lung 
cancer patients. This was done by analyzing the motion of 
implanted Visicoil markers in the projection images of daily 
setup CBCT scans and in intra-treatment kV images. 
Materials and Methods: Four patients with Visicoil markers 
implanted by EBUS bronchoscope in tumor and LN targets 
received radiotherapy for lung cancer delivered by IMRT in 
30-33 fractions.  
Before each fraction, a setup CBCT scan with ~675 
projections was acquired during a full gantry rotation. The 
Visicoil positions were segmented offline in each projection 
image using a semi-automatic template-based algorithm. 
From the segmented Visicoil positions the 3D Visicoil 
trajectories were estimated by a probability-based method. 
The 3D Visicoil motion during the entire treatment delivery 
was determined similarly at every third fraction from 5 Hz 
fluoroscopic kV images acquired perpendicular to the 
treatment beam. The CBCT scans were used for daily online 
soft tissue match on the primary tumor.  
One of the four patients was selected for presentation in this 
abstract. This patient had four Visicoil markers implanted; 
one in the primary tumor (right hilum) and three in the 
mediastinal LN targets (LN stations 4R, 7 and 11R).  
Results: The motion of all four Visicoils during the setup 
CBCT scan is shown in Figure 1 for the first 24 fractions (only 
cranial-caudal (CC) motion presented). The LN motion is 
shown relative to the mean position of the tumor in each 
fraction, i.e. the shifts from fraction to fraction represent 
interfraction shifts relative to the tumor. The table presents 
the span of these interfraction shifts of the LNs relative to 
the tumor position (part a), and the intrafraction motion 
amplitudes in the left-right (LR), CC, and anterior-posterior 
(AP) directions for all four targets (part b). The tumor had 
substantially larger CC motion than the LNs. Frequency 
analysis showed that the tumor only had respiratory induced 
motion, with no cardiac component, whereas the LNs had a 
considerable cardiac induced motion. In particular, the LN 4R 
mainly moved in the AP and LR directions due to dominant 
cardiac motion (Table 1b). Shifts exceeding 5mm were 
observed for some fractions for the mean LN position relative 
to the mean tumor position along both LR, CC, and AP 
direction (see Figure 1). 
